Specialists in biomolecules
All about chondroprotection
Bioibérica researches, develops, manufactures and markets the main chondroprotective molecules for treating osteoarthritis: Chondroitin sulfate, glucosamine and hyaluronic acid, drugs with a high efficacy, safety and cost profile.
Here at Bioibérica we are also strongly committed to research into personalized medicine and we have the first genetic test for predicting the progression of osteoarthritis of the knee.
Condroprotección is a magazine that presents the most recent research and techniques related to joint protection, providing advanced information for specialists.